Key Record Dates
ClinicalTrials.gov Identifier: | NCT04730349 |
---|---|
Brief Title: | A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer (PIVOT IO 020) |
First Submitted : | January 26, 2021 |
First Submitted that Met QC Criteria : | January 26, 2021 |
First Posted : | January 29, 2021 |
Results First Submitted : | December 21, 2022 |
Results First Posted with QC Comments : | January 18, 2023 |
Results First Submitted that Met QC Criteria : | March 22, 2023 |
Results First Posted : | March 24, 2023 |
Last Update Submitted that Met QC Criteria : | March 22, 2023 |
Last Update Posted : | March 24, 2023 |